HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes

被引:29
|
作者
Undlien, DE [1 ]
Kockum, I
Ronningen, KS
Lowe, R
Saanjeevi, CB
Graham, J
Lie, BA
Akselsen, HE
Lernmark, Å
Thorsby, E
机构
[1] Univ Oslo, Natl Hosp, Inst Immunol, N-0027 Oslo, Norway
[2] Karolinska Inst, Dept Mol Med, Stockholm, Sweden
[3] Natl Inst Publ Hlth, Dept Populat Hlth Sci, Oslo, Norway
[4] Univ Washington, Dept Med, Seattle, WA USA
[5] Univ Washington, Dept Biostat, Seattle, WA USA
来源
TISSUE ANTIGENS | 1999年 / 54卷 / 06期
关键词
disease susceptibility; genotype; HLA class II antigens; insulin-dependent diabetes mellitus; transmission disequilibrium test (TDT);
D O I
10.1034/j.1399-0039.1999.540602.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Type 1 diabetes is a complex disease where numerous genes are involved in the pathogenesis. Genes that account for approximately 50% of the familial clustering of the disease are located within or in the vicinity of the HLA complex on chromosome 6. Some DRB1, DQA1 and DQB1 genes are known to be involved, in addition to as yet unidentified HLA-linked genes. The DR4-DQ8 and DR3-DQ2 haplotypes are known to confer high risk for developing the disease, particularly when occurring together. Approximately 10% of patients, however,do not carry any of these high-risk HLA class II haplotypes. We have performed genotyping of DRB1, DQA1 and DQB1 alleles in non-DR3-DQ2/non-DR4-DQ8 patients and controls from Sweden and Norway to test if any HLA associations were observed in these patients our results clearly demonstrate several statistically significant differences in the frequency of HLA haplotypes between patients and controls. Case-control analysis including the relative predispositional effect test, and transmission disequilibrium test (TDT) analysis in Norwegian type 1 diabetes families revealed that the DQA1*03-DQB1*0301, DQA1*0401-DQB1*0402, DQA1*0101-DQB1*0501, DQA1*03-DQB1*0303 and DQA1*0102-DQB1*0604 haplotypes may also confer risk. Our analyses also supported independent risks of certain DRB1 alleles. The study clearly demonstrates that HLA associations in type 1 diabetes extends far beyond the well-known associations with the DR4-DQ8 and DR3-DQ2 haplotypes. Our data suggest that there is a hierarchy of HLA class II haplotypes conferring risk to develop type 1 diabetes.
引用
收藏
页码:543 / 551
页数:9
相关论文
共 50 条
  • [1] High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease
    Schweiger, Darja Smigoc
    Mendez, Andrijana
    Jamnik, Sabina Kunilo
    Bratanic, Nina
    Bratina, Natasa
    Battelino, Tadej
    Brecelj, Jernej
    Vidan-Jeras, Blanka
    [J]. AUTOIMMUNITY, 2016, 49 (04) : 240 - 247
  • [2] HIGH RISK GENOTYPES HLA-DR3-DQ2/DR3-DQ2 AND DR3-DQ2/DR4-DQ8 IN CO-OCCURRENCE OF TYPE 1 DIABETES AND CELIAC DISEASE
    Schweiger, Darja Smigoc
    Mendez, Andrijana
    Jamnik, Sabina Kunilo
    Bratanic, Nina
    Bratina, Natasa
    Battelino, Tadej
    Brecelj, Jernej
    Vidan-Jeras, Blanka
    [J]. HLA, 2016, 87 (04) : 233 - 233
  • [3] Early Onset of Diabetes in the Proband Is the Major Determinant of Risk in HLA DR3-DQ2/DR4-DQ8 Siblings
    Gillespie, Kathleen M.
    Aitken, Rachel J.
    Wilson, Isabel
    Williams, Alistair J. K.
    Bingley, Polly J.
    [J]. DIABETES, 2014, 63 (03) : 1041 - 1047
  • [4] Index60 Is More Strongly Associated with the Highest Type 1 Diabetes (T1D) Risk HLA DR3-DQ2/DR4-DQ8 (DQ2/DQ8) Genotype than Glucose Measures
    Redondo, Maria J.
    Geyer, Susan
    Ismail, Heba M.
    Herold, Kevan C.
    Pugliese, Alberto
    Palmer, Jerry P.
    Sosenko, Jay
    [J]. DIABETES, 2018, 67
  • [5] D6S2223 alleles associated with risk of IDDM in DR3-DQ2/DR4-DQ8 heterozygotes
    Park, Y
    Jospe, E
    Babu, S
    Eisenbarth, GS
    [J]. DIABETES, 1999, 48 : A183 - A183
  • [6] HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia
    Ilonen, Jorma
    Kocova, Mirjana
    Lipponen, Kati
    Sukarova-Angelovska, Elena
    Jovanovska, Aleksandra
    Knip, Mikael
    [J]. HUMAN IMMUNOLOGY, 2009, 70 (06) : 461 - 463
  • [7] Intralymphatic GAD-Alum (Diamyd®) improves glycemic control in Type 1 diabetes patients carrying HLA DR3-DQ2
    Ludvigsson, J.
    Nowak, C.
    Hannelius, U.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [8] INTRALYMPHATIC GAD-ALUM (DIAMYD®) IMPROVES GLYCEMIC CONTROL IN TYPE 1 DIABETES PATIENTS CARRYING HLA DR3-DQ2
    Ludvigsson, J.
    Nowak, C.
    Hannelius, U.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A49 - A49
  • [9] Paediatric celiac patients carrying the HLA-DR7-DQ2 and HLA-DR3-DQ2 haplotypes display small clinical differences
    Delgado, Juan F.
    Amengual, Maria J.
    Veraguas, Ana
    Rodriguez, Encarnacion
    de Los Santos, Mariela M.
    Guallarte, Maria P.
    [J]. ACTA PAEDIATRICA, 2014, 103 (06) : E238 - E242
  • [10] Relationship between HLA Class I Genes and High-Risk HLA-DR-DQ Haplotypes in Chinese Type 1 Diabetes
    Wang, Zhixiao
    Xu, Xinyu
    Gu, Rong
    Chen, Heng
    Wu, Xiangmei
    Xu, Kuanfeng
    Zhang, Mei
    Zhou, Hongwen
    Liu, Yu
    Yang, Tao
    [J]. DIABETES, 2010, 59 : A331 - A331